• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

HEXTEND (6% Hetastarch in Lactated Electrolyte Injection)

NDA Number: BN200952
Manufacturer: BioTime, Inc.
Product name: HEXTEND® (6% Hydroxyethyl Starch in Lactated Electrolyte Injection)

  • Indicated in the treatment of hypovolemia when plasma volume expansion is desired. It is not a substitute for blood or plasma.